Assessment of the hepatic circulation in humans: New concepts based on evidence derived from a D-sorbitol clearance method

被引:28
作者
Molino, G
Avagnina, P
Belforte, G
Bircher, J
机构
[1] A Azienda Osped San Giovanni Battista, Div Gen Med, I-10126 Turin, Italy
[2] Univ Turin, Dipartimento Sci Clin & Biol, I-10124 Turin, Italy
[3] Politecn Torino, Dipartimento Automat & Informat, Turin, Italy
[4] Univ Witten Herdecke, Fak Med, Witten, Germany
来源
JOURNAL OF LABORATORY AND CLINICAL MEDICINE | 1998年 / 131卷 / 05期
关键词
D O I
10.1016/S0022-2143(98)90139-1
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
D-Sorbitol (SOR) is safe, is easy to measure, and has an exceptionally high extraction ratio in the normal liver of 0.93 +/- 0.05 (mean +/- SD). Together with the general interest in hepatic hemodynamics, these facts motivated us to review the usefulness of this compound for the assessment of liver plasma flow in humans. We concluded that in subjects without liver disease the nonrenal clearance of SOR-measured noninvasively-very closely approximates hepatic plasma flow. Because of its lower and more variable extraction ratio, indocyanine green should no longer be used without hepatic vein catheterization. Even in patients with cirrhosis, SOR exhibits higher hepatic extraction ratios than indocyanine green. To fully explore the potential of SOR in the evaluation of such patients attention needs to be paid to the complex changes in architecture and function occurring in this disease. In cirrhotics the noninvasively measured nonrenal clearance of SOR presumably approximates the flow through intact and capillarized sinusoids (functional flow) and reflects the amount of blood having functional contact with hepatocytes. The theoretic background of the method, its accuracy, further research needs, and potentials of various approaches are discussed in detail.
引用
收藏
页码:393 / 405
页数:13
相关论文
共 87 条
[1]  
ANDERSON MF, 1981, MEASUREMENT BLOOD FL, P395
[2]   CONTROL OF BLOOD-FLOW IN A LARGE SURFACE WOUND [J].
AULICK, LH ;
BAZE, WB ;
MCLEOD, CG ;
WILMORE, DW .
ANNALS OF SURGERY, 1980, 191 (02) :249-258
[3]   Assessment of metabolic liver function and hepatic blood flow during cardiopulmonary bypass [J].
Autschbach, R ;
Falk, V ;
Lange, H ;
Oellerich, M ;
Walther, T ;
Mohr, FW ;
Dalichau, H .
THORACIC AND CARDIOVASCULAR SURGEON, 1996, 44 (02) :76-80
[4]   Assessment of functional liver mass and plasma flow in acromegaly before and after long-term treatment with octreotide [J].
Avagnina, P ;
Martini, M ;
Terzolo, M ;
Sansoe, G ;
Peretti, P ;
Tinivella, P ;
Pia, A ;
Molino, G ;
Angeli, A .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1996, 45 (01) :109-113
[5]   EFFECTS OF NIFEDIPINE ON FUNCTIONAL LIVER PLASMA-FLOW IN NORMAL SUBJECTS AND IN PATIENTS WITH CIRRHOSIS [J].
AVAGNINA, P ;
SANSOE, G ;
MARTINI, M ;
PERETTI, P ;
TINIVELLA, M ;
MOLINO, G .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (03) :368-373
[6]  
Balestra G., 1988, Medical Informatics: Computers in Clinical Medicine, P191
[7]  
BALESTRA G, 1989, P 11 ANN INT C IEEE, P250
[8]  
BARSTOW L, 1990, PHARMACOTHERAPY, V10, P280
[9]  
BASS L, 1976, J THEOR BIOL, V61, P392
[10]   CLINICAL PHARMACOKINETICS OF LIGNOCAINE [J].
BENOWITZ, NL ;
MEISTER, W .
CLINICAL PHARMACOKINETICS, 1978, 3 (03) :177-201